Home/Filings/4/0001096906-24-002248
4//SEC Filing

Hunter Robert Gail 4

Accession 0001096906-24-002248

CIK 0000318673other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 9:39 AM ET

Size

35.3 KB

Accession

0001096906-24-002248

Insider Transaction Report

Form 4
Period: 2024-12-06
Transactions
  • Award

    Director Stock Option (right to buy)

    2017-12-01$3.44/sh+1,442$4,96020,072 total
    Exercise: $3.44From: 2018-03-01Exp: 2027-12-01Class A Common Stock (1,442 underlying)
  • Award

    Director Stock Option (right to buy)

    2020-03-27$2.99/sh+7,476$22,35343,642 total
    Exercise: $2.99From: 2020-06-27Exp: 2030-03-27Class A Common Stock (7,476 underlying)
  • Award

    Director Stock Option (right to buy)

    2015-12-07$4.13/sh+1,592$6,5759,543 total
    Exercise: $4.13From: 2016-03-07Exp: 2025-12-07Class A Common Stock (1,592 underlying)
  • Award

    Director Stock Option (right to buy)

    2018-11-03$3.96/sh+8,244$32,64628,316 total
    Exercise: $3.96From: 2019-02-28Exp: 2028-11-30Class A Common Stock (8,244 underlying)
  • Award

    Director Stock Option (right to buy)

    2015-12-04$4.13/sh+7,951$32,8387,951 total
    Exercise: $4.13From: 2016-03-04Exp: 2025-12-04Class A Common Stock (7,951 underlying)
  • Award

    Director Stock Option (right to buy)

    2022-12-02$5.85/sh+7,718$45,15058,306 total
    Exercise: $5.85From: 2023-03-02Exp: 2032-12-02Class A Common Stock (7,718 underlying)
  • Award

    Director Stock Option (right to buy)

    2023-12-01$7.59/sh+8,400$63,75666,706 total
    Exercise: $7.59From: 2023-03-01Exp: 2033-12-01Class A Common Stock (8,400 underlying)
  • Award

    Director Stock Option (right to buy)

    2016-12-07$4.76/sh+1,514$7,20718,630 total
    Exercise: $4.76From: 2017-03-07Exp: 2026-12-07Class A Common Stock (1,514 underlying)
  • Award

    Director Stock Option (right to buy)

    2016-12-02$4.55/sh+7,573$34,45717,116 total
    Exercise: $4.55From: 2017-03-02Exp: 2026-12-02Class A Common Stock (7,573 underlying)
  • Award

    Director Stock Option (right to buy)

    2019-12-06$4.12/sh+7,850$32,34236,166 total
    Exercise: $4.12From: 2020-03-06Exp: 2029-12-26Class A Common Stock (7,850 underlying)
  • Award

    Director Stock Option (right to buy)

    2021-12-03$7.39/sh+6,946$51,33150,588 total
    Exercise: $7.39From: 2022-03-03Exp: 2031-12-03Class A Common Stock (6,946 underlying)
  • Award

    Director Stock Option (right to buy)

    2024-12-06$13.08/sh+10,400$136,03277,106 total
    Exercise: $13.08From: 2025-03-06Exp: 2034-12-06Class A Common Stock (10,400 underlying)
Footnotes (12)
  • [F1]This option was granted on December 4, 2015 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.
  • [F10]This option was granted on December 2, 2022 as an option for 7,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.48 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 14, 2023 and July 12, 2024.
  • [F11]This option was granted on December 1, 2023 as an option for 8,000 shares of Class A Common Stock under the 2022 Equity Incentive Plan at an exercise price of $7.99 per share, but adjusted pursuant to the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 12, 2024.
  • [F12]This option was granted on December 6, 2024 as an option for 10,400 shares of Class A Common Stock under the 2022 Equity Incentive Plan at an exercise price of $13.08 per share. The options granted vest quarterly, with 100% vesting on December 6, 2025.
  • [F2]This option was granted on December 7, 2015 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.72 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.
  • [F3]This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.
  • [F4]This option was granted on December 7, 2016 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.36 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.
  • [F5]This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.
  • [F6]This option was granted on November 30, 2018 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.
  • [F7]This option was granted on December 6, 2019 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.46 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.
  • [F8]This option was granted on March 27, 2020 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $3.76 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.
  • [F9]This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023 and July 12, 2024.

Issuer

SECURITY NATIONAL FINANCIAL CORP

CIK 0000318673

Entity typeother

Related Parties

1
  • filerCIK 0001298091

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 9:39 AM ET
Size
35.3 KB